Panadol Ultra Rapide (Paracetamol, Caffeine, Codeine Phosphate Hemihydrate)

Paracetamol, the active ingredient in Panadol Ultra Rapide, is an analgesic combination presented as a tablet for oral use. It treats mild to moderate pain and reduces fever in adults and children when appropriate. GNH USA supplies Panadol Ultra Rapide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Panadol Ultra Rapide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Panadol Ultra Rapide combines analgesic and antipyretic activity to relieve pain and fever across several common conditions.

- Headache: provides rapid relief of tension‑type and migraine‑associated pain. - Dental pain: reduces discomfort following dental procedures or toothache. - Musculoskeletal pain: eases aches from strains, sprains and low‑back tension. - Fever: lowers elevated body temperature in febrile states. - Cold and flu symptoms: alleviates headache and body aches that accompany viral upper‑respiratory infections.

Paracetamol, caffeine and codeine together are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset may be experienced. - Drowsiness: a feeling of sleepiness or reduced alertness. - Constipation: reduced bowel movements, especially with regular use. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivation. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing, particularly at higher opioid doses. - Hepatotoxicity: liver injury from excessive paracetamol exposure. - Allergic reactions: rash, itching, swelling or anaphylaxis. - Seizures: rare occurrence, often linked to overdose. - Severe constipation or bowel obstruction. - Dependence or withdrawal symptoms with prolonged codeine use.

When using Panadol Ultra Rapide, consider the following safety measures:

- Dose limits: adhere to maximum daily paracetamol intake to avoid liver damage. - Alcohol use: limit alcohol consumption as it may increase hepatotoxic risk. - Pre‑existing liver disease: use only under medical supervision. - Respiratory conditions: caution in patients with asthma or chronic obstructive pulmonary disease. - Opioid sensitivity: monitor for signs of opioid‑related side effects. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Panadol Ultra Rapide may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Warfarin: increased bleeding risk due to enhanced anticoagulant effect. - MAO inhibitors: heightened risk of serotonin syndrome. - Other opioid analgesics: additive respiratory depression.

Moderate Interactions (Monitor Closely): - Antiepileptic drugs (e.g., carbamazepine): may reduce codeine effectiveness. - CYP3A4 inhibitors (e.g., erythromycin): can increase codeine plasma levels. - CNS depressants (e.g., benzodiazepines): may amplify drowsiness. - Alcohol: raises hepatotoxic potential of paracetamol. - Diuretics: may affect fluid balance and kidney function.